Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis.

ABSTRACT:

SUBMITTER: Doms J 

PROVIDER: S-EPMC7229714 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature